Trading Report: Today, Puretech Health PLC’s (PRTC) “Buy” Rating Reiterate at Peel Hunt

Today, Puretech Health PLC’s (PRTC) “Buy” Rating Reiterate at Peel Hunt

Puretech Health PLC (LON:PRTC)‘s stock had its “buy” rating reiterated by investment analysts at Peel Hunt in a research report issued on Wednesday. They presently have a GBX 238 ($2.95) price objective on the stock. Peel Hunt’s price objective points to a potential upside of 83.08% from the company’s previous close.

A number of other research firms have also recently weighed in on PRTC. Jefferies Group reaffirmed a “buy” rating and issued a GBX 235 ($2.92) price objective on shares of Puretech Health PLC in a report on Thursday, August 25th. Numis Securities Ltd reaffirmed a “buy” rating and issued a GBX 220 ($2.73) price objective on shares of Puretech Health PLC in a report on Wednesday, September 7th. Finally, Liberum Capital reaffirmed a “buy” rating and issued a GBX 196 ($2.43) price objective on shares of Puretech Health PLC in a report on Wednesday, August 17th.

Puretech Health PLC (LON:PRTC) remained flat at GBX 130.00 during trading on Wednesday. The company had a trading volume of 68,301 shares. The company’s market cap is GBX 298.79 million. The company has a 50-day moving average of GBX 131.75 and a 200 day moving average of GBX 142.66. Puretech Health PLC has a 52-week low of GBX 118.00 and a 52-week high of GBX 177.00.

Related posts

Leave a Comment